Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression | |
Wu, Jingjing; Chen, Hongfeng; Meng, Tian; Sheng, Jiayu; Zhang, Yuzhu; Wang, Bing; Ye, Meina; Chen, Hao | |
刊名 | BIOMEDICINE & PHARMACOTHERAPY |
2019 | |
卷号 | 115 |
关键词 | HCP5 Cisplatin resistance Triple-Negative breast cancer PTEN |
ISSN号 | 0753-3322 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3631789 |
专题 | 上海中医药大学 |
推荐引用方式 GB/T 7714 | Wu, Jingjing,Chen, Hongfeng,Meng, Tian,et al. Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression[J]. BIOMEDICINE & PHARMACOTHERAPY,2019,115. |
APA | Wu, Jingjing.,Chen, Hongfeng.,Meng, Tian.,Sheng, Jiayu.,Zhang, Yuzhu.,...&Chen, Hao.(2019).Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.BIOMEDICINE & PHARMACOTHERAPY,115. |
MLA | Wu, Jingjing,et al."Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression".BIOMEDICINE & PHARMACOTHERAPY 115(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论